Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 271: 137-48, 2014 Jun 20.
Article in English | MEDLINE | ID: mdl-24769433

ABSTRACT

Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is a transcriptional coactivator known to regulate gene programs in a cell-specific manner in energy-demanding tissues, and its dysfunction has been implicated in numerous neurological and psychiatric disorders. Previous work from the Cowell laboratory indicates that PGC-1α is concentrated in inhibitory interneurons and is required for the expression of the calcium buffer parvalbumin (PV) in the cortex; however, the impact of PGC-1α deficiency on inhibitory neurotransmission in the motor cortex is not known. Here, we show that mice lacking PGC-1α exhibit increased amplitudes and decreased frequency of spontaneous inhibitory postsynaptic currents in layer V pyramidal neurons. Upon repetitive train stimulation at the gamma frequency, decreased GABA release is observed. Furthermore, PV-positive interneurons in PGC-1α -/- mice display reductions in intrinsic excitability and excitatory input without changes in gross interneuron morphology. Taken together, these data show that PGC-1α is required for normal inhibitory neurotransmission and cortical PV-positive interneuron function. Given the pronounced motor dysfunction in PGC-1α -/- mice and the essential role of PV-positive interneurons in maintenance of cortical excitatory:inhibitory balance, it is possible that deficiencies in PGC-1α expression could contribute to cortical hyperexcitability and motor abnormalities in multiple neurological disorders.


Subject(s)
Motor Cortex/physiology , Neural Inhibition/physiology , Neurons/physiology , Synaptic Transmission/physiology , Transcription Factors/deficiency , Action Potentials/physiology , Animals , Electric Stimulation , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Inhibitory Postsynaptic Potentials/physiology , Interneurons/pathology , Interneurons/physiology , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Motor Cortex/pathology , Neurons/pathology , Parvalbumins/metabolism , Patch-Clamp Techniques , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Pyramidal Cells/pathology , Pyramidal Cells/physiology , Tissue Culture Techniques , Transcription Factors/genetics , Transcription Factors/metabolism , gamma-Aminobutyric Acid/metabolism
2.
Neurobiol Dis ; 62: 160-71, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24121117

ABSTRACT

Recent evidence suggests that interneurons are involved in the pathophysiology of Huntington Disease (HD). Abnormalities in the function of interneurons expressing the calcium buffer parvalbumin (PV) have been observed in multiple mouse models of HD, although it is not clear how PV-positive interneuron dysfunction contributes to behavioral and synaptic deficits. Here, we use the cre-lox system to drive expression of mutant huntingtin (mthtt) in parvalbumin (PV)-positive neurons and find that mutant mice exhibit diffuse mthtt immunoreactivity in PV-rich areas at 10months of age and mthtt aggregates in PV-positive processes at 24months of age. At midlife, mutant mice are hyperactive and display impaired GABA release in the motor cortex, characterized by reduced miniature inhibitory events and severely blunted responses to gamma frequency stimulation, without a loss of PV-positive interneurons. In contrast, 24month-old mutant mice show normalized behavior and responses to gamma frequency stimulation, possibly due to compensatory changes in pyramidal neurons or the formation of inclusions with age. These data indicate that mthtt expression in PV-positive neurons is sufficient to drive a hyperactive phenotype and suggest that mthtt-mediated dysfunction in PV-positive neuronal populations could be a key factor in the hyperkinetic behavior observed in HD. Further clarification of the roles for specific PV-positive populations in this phenotype is warranted to definitively identify cellular targets for intervention.


Subject(s)
Hyperkinesis/metabolism , Inhibitory Postsynaptic Potentials , Interneurons/physiology , Motor Cortex/physiopathology , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Parvalbumins/metabolism , Age Factors , Animals , Brain/metabolism , Female , Huntingtin Protein , Hyperkinesis/physiopathology , Male , Mice , Mice, Transgenic , Mutation , Nerve Tissue Proteins/genetics , Nuclear Proteins/genetics , gamma-Aminobutyric Acid/metabolism
3.
Exp Neurol ; 240: 96-102, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23195593

ABSTRACT

Huntington Disease (HD) is an autosomal dominant neurological disorder characterized by motor, psychiatric and cognitive disturbances. Recent evidence indicates that the viability and function of cerebellar Purkinje cells (PCs) are compromised in an aggressive mouse model of HD. Here we investigate whether this is also the case in the HdhQ200 knock-in mouse model of HD. Using quantitative-real time-PCR and immunofluorescence, we observed a loss of the PC marker and calcium buffer calbindin in 50week-old symptomatic mice. Reductions were also observed in parvalbumin and glutamic acid decarboxylase protein expression, most markedly in the molecular cell layer. Stereological analysis revealed an overall reduction in the PC population in HdhQ200/Q200 mice by nearly 40%, and loose patch electrophysiology of remaining PCs indicated a reduction in firing rate in HD mice compared to control littermates. Taken together, these data demonstrate that PC survival and function are compromised in a mouse model of adult-onset HD and suggest that further experiments should investigate the contribution of PC death and dysfunction to HD-associated motor impairment.


Subject(s)
Huntington Disease/genetics , Huntington Disease/pathology , Nerve Tissue Proteins/genetics , Nuclear Proteins/genetics , Purkinje Cells/pathology , Animals , Cerebellar Cortex/pathology , Cerebellar Cortex/physiopathology , Disease Models, Animal , Female , Gene Knock-In Techniques/methods , Huntingtin Protein , Huntington Disease/physiopathology , Male , Mice , Mice, Neurologic Mutants , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Purkinje Cells/physiology
4.
Exp Neurol ; 236(1): 171-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22579526

ABSTRACT

Huntington Disease (HD) is a devastating neurological disorder characterized by progressive deterioration of psychiatric, motor, and cognitive function. Purkinje cells (PCs), the output neurons of the cerebellar cortex, have been found to be vulnerable in multiple CAG repeat disorders, but little is known about the involvement of PC dysfunction in HD. To investigate possible PC abnormalities, we performed quantitative real time PCR, Western blot analysis, and immunohistochemistry experiments to explore the changes in PC markers in the R6/2 mouse model of severe HD. There were reductions in the transcript and protein levels of the calcium-binding proteins parvalbumin and calbindin, as well as the enzyme glutamic acid decarboxylase 67. Immunohistochemistry supported these results, with the most substantial changes occurring in the PC layer. To determine whether the reductions in PC marker expression were due to cell loss, we performed stereology on both presymptomatic and end-stage R6/2 mice. Stereological counts indicated a significant reduction in PC number by end-stage but no change in presymptomatic animals (4 weeks of age). To assess cellular function prior to cell loss and symptom onset, we measured spontaneous firing in PCs from 4-week old animals and found a striking deficit in PC firing as indicated by a 57% decrease in spike rate. Interestingly, huntingtin inclusions were not widely observed in PCs until 12 weeks of age, indicating that soluble huntingtin and/or abnormalities in other cell types may contribute to PC dysfunction. Considering the roles for PCs in motor control, these data suggest that early PC dysfunction potentially contributes to motor impairment in this model of HD.


Subject(s)
Huntington Disease/metabolism , Huntington Disease/pathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Purkinje Cells/pathology , Age Factors , Animals , Disease Models, Animal , Huntingtin Protein , Huntington Disease/genetics , Male , Mice , Mice, Inbred Strains , Mice, Mutant Strains , Phenotype
5.
Am J Sports Med ; 14(6): 501-10, 1986.
Article in English | MEDLINE | ID: mdl-3799879

ABSTRACT

An electromyographic study of the lower extremity muscles was undertaken in order to compare jogging, running, and sprinting. The study demonstrated that as the speed of gait increased, the support phase decreased, from 620 msec for walking to 260 msec for jogging to 220 msec for running to 140 msec for sprinting. The electromyographic data demonstrated that all muscle groups except the hip flexor and adductor longus were active during foot descent, floor contact, and midsupport. There was absence of muscle function during the late toe-off phase except that demonstrated by the adductor longus and the abdominal muscles during sprinting. The main muscle group that appears to increase the speed of gait is that of the hip flexors, which is closely linked to the knee extensors in order to propel the body forward in the line of progression. There was little or no activity in the gastrocnemius or in the intrinsic muscles of the foot about the time of toe-off, leading the authors to conclude that push-off per se does not appear to occur.


Subject(s)
Leg/physiology , Running , Adult , Ankle Joint/physiology , Electromyography , Gait , Hip/physiology , Humans , Knee Joint/physiology , Male , Motion Pictures , Muscles/physiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...